Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Bone marrow stroma secreted cytokines protect JAK2V617F-mutated cells from the effects of a JAK2 Inhibitor (CROSBI ID 173526)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Manshouri, Taghi ; Estrov, Zeev ; Quintás-Cardama, Alfonso ; Burger, Jan ; Zhang, Ying ; Livun, Ana ; Knez, Liza ; Harris, David ; Creighton, Chad J. ; Kantarjian, Hagop M. et al. Bone marrow stroma secreted cytokines protect JAK2V617F-mutated cells from the effects of a JAK2 Inhibitor // Cancer research (Baltimore), 71 (2011), 11; 3831-3840. doi: 10.1158/0008-5472.CAN-10-4002

Podaci o odgovornosti

Manshouri, Taghi ; Estrov, Zeev ; Quintás-Cardama, Alfonso ; Burger, Jan ; Zhang, Ying ; Livun, Ana ; Knez, Liza ; Harris, David ; Creighton, Chad J. ; Kantarjian, Hagop M. ; Verstovšek, Srđan

engleski

Bone marrow stroma secreted cytokines protect JAK2V617F-mutated cells from the effects of a JAK2 Inhibitor

Signals emanating from the bone marrow microenvironment, such as stromal cells, are thought to support the survival and proliferation of the malignant cells in patients with myeloproliferative neoplasms (MPN). To examine this hypothesis, we established a coculture platform [cells cocultured directly (cell-on-cell) or indirectly (separated by micropore membrane)] designed to interrogate the interplay between Janus activated kinase 2-V617F (JAK2(V617F))- positive cells and the stromal cells. Treatment with atiprimod, a potent JAK2 inhibitor, caused marked growth inhibition and apoptosis of human (SET-2) and mouse (FDCP-EpoR) JAK2(V617F)-positive cells as well as primary blood or bone marrow mononuclear cells from patients with polycythemia vera ; however, these effects were attenuated when any of these cell types were cocultured (cell-on- cell) with human marrow stromal cell lines (e.g., HS5, NK.tert, TM-R1). Coculture with stromal cells hampered the ability of atiprimod to inhibit phosphorylation of JAK2 and the downstream STAT3 and STAT5 pathways. This protective effect was maintained in noncontact coculture assays (JAK2(V617F)-positive cells separated by 0.4-μm- thick micropore membranes from stromal cells), indicating a paracrine effect. Cytokine profiling of supernatants from noncontact coculture assays detected distinctly high levels of interleukin 6 (IL-6), fibroblast growth factor (FGF), and chemokine C-X-C-motif ligand 10 (CXCL-10)/IFN-γ- inducible 10-kD protein (IP-10). Anti-IL-6, -FGF, or -CXCL-10/IP-10 neutralizing antibodies ablated the protective effect of stromal cells and restored atiprimod-induced apoptosis of JAK2(V617F)-positive cells. Therefore, our results indicate that humoral factors secreted by stromal cells protect MPN clones from JAK2 inhibitor therapy, thus underscoring the importance of targeting the marrow niche in MPN for therapeutic purposes.

myeloproliferative neoplasms; JAK2(V617F); atiprimod; IL-6

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

71 (11)

2011.

3831-3840

objavljeno

0008-5472

10.1158/0008-5472.CAN-10-4002

Povezanost rada

Temeljne medicinske znanosti, Biologija

Poveznice
Indeksiranost